Article
Distinct sets of molecular characteristics define tumor-rejecting neoantigens
2024-02-16
Abstract excerpt
Challenges in identifying tumor-rejecting neoantigens limit the efficacy of neoantigen vaccines to treat cancers, including cutaneous squamous cell carcinoma (cSCC). A minority of human cSCC tumors shared neoantigens, supporting the need for personalized vaccines. Using a UV-induced mouse cSCC model which recapitulated the mutational signature and driver mutations found in human disease, we found that CD8 T cells...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- dd69caf2-134c-51c3-9cce-fc6ed439c578
- DOI
- 10.1101/2024.02.13.579546
